Cartalax vs Humanin
Side-by-side comparison of Cartalax and Humanin: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
Cartalax
Humanin
Cartalax
Cartalax is a short synthetic peptide developed in Russia by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology, positioned as a "cartilage bioregulator" intended to…
Lowest listed price: $49.99 across 3 listings
Full Cartalax profileHumanin
Humanin is a 24-amino-acid peptide (MAPRGFSCLLLLTSEIDLPVKRRA) encoded within the mitochondrial 16S ribosomal RNA gene and translated from a short open reading frame that was not recognized as biologically active until…
Lowest listed price: $85.60 across 2 listings
Full Humanin profileSide-by-side comparison
| Attribute | Cartalax | Humanin |
|---|---|---|
| Category | Recovery | Recovery |
| Research Stage | Preclinical | Preclinical |
| Mechanism of Action | Mechanism of Action Cartalax's proposed mechanism is the Khavinson short-peptide framework applied to cartilage: passive membrane permeation, nuclear import, and sequence-selective chromatin modulation producing chondrocyte-favourable transcriptional shifts.… | Humanin signals through a heterotrimeric cell-surface receptor complex consisting of ciliary neurotrophic factor receptor alpha (CNTFR-alpha), WSX-1 (also known as IL-27R-alpha), and glycoprotein 130 (gp130) ([Ying et al., 2004]; [Hashimoto et al., 2009]).… |
| Half-Life | No published human or animal pharmacokinetic data for Cartalax. As a small (~446.5 Da) tetrapeptide, rapid plasma hydrolysis (on the order of minutes) is expected, consistent with other Khavinson short peptides, but this has not been directly measured. | Short - on the order of minutes. Wild-type 24-amino-acid humanin is rapidly cleared from plasma (rodent data); the S14G analog (HNG) is more metabolically stable. No human pharmacokinetic data exist. |
| Typical Dose Range | 20 mg oral/sublingual once daily for 10 days; 60-90 day washout | Research compound — no established human doses |
| Dosing Frequency | Once daily | Once daily subcutaneous in anecdotal use (some split twice daily for the short half-life); no validated human regimen |
| Administration | — | — |
| Side Effects | Side Effects and Safety Cartalax has been used in Russian clinical settings for roughly 20 years with a sparse adverse-event literature — reassuring in direction, insufficient for confident pharmacovigilance. Reported short-term adverse effects -… | The side effect profile of humanin in humans is not established because no properly designed clinical trials have been published. The preclinical safety profile in rodents is reassuring: across numerous studies using wild-type humanin and HNG at doses… |
| Molecular Weight | 446.5 Da (C18H30N4O9) | 2687.26 Da |
| Common Vial Sizes | — | — |
Price History
3 data points- Ion Peptide
- Disguised Alpha
- LB
Price History
2 data points- Disguised Alpha
- LB
Cartalax: potential benefits
- Joint and cartilage repair support
- Connective tissue maintenance
- Anti-aging effects on musculoskeletal system
- Improved joint mobility
Humanin: potential benefits
- Cytoprotective effects
- Anti-apoptotic properties
- Neuroprotective potential
- Cardioprotective effects
- Cellular stress resistance
Frequently asked
What's the difference between Cartalax and Humanin?
Cartalax is a recovery that mechanism of action cartalax's proposed mechanism is the khavinson short-peptide framework applied to cartilage: passive membrane permeation, nuclear import, and sequence-selective…. Humanin is a recovery that humanin signals through a heterotrimeric cell-surface receptor complex consisting of ciliary neurotrophic factor receptor alpha (cntfr-alpha), wsx-1 (also known as il-27r-alpha),…. The two differ in mechanism, half-life (No published human or animal pharmacokinetic data for Cartalax. As a small (~446.5 Da) tetrapeptide, rapid plasma hydrolysis (on the order of minutes) is expected, consistent with other Khavinson short peptides, but this has not been directly measured. vs Short - on the order of minutes. Wild-type 24-amino-acid humanin is rapidly cleared from plasma (rodent data); the S14G analog (HNG) is more metabolically stable. No human pharmacokinetic data exist.), and typical dose range.
Which has the longer half-life, Cartalax or Humanin?
Cartalax has a half-life of No published human or animal pharmacokinetic data for Cartalax. As a small (~446.5 Da) tetrapeptide, rapid plasma hydrolysis (on the order of minutes) is expected, consistent with other Khavinson short peptides, but this has not been directly measured.. Humanin has a half-life of Short - on the order of minutes. Wild-type 24-amino-acid humanin is rapidly cleared from plasma (rodent data); the S14G analog (HNG) is more metabolically stable. No human pharmacokinetic data exist.. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Which is cheaper, Cartalax or Humanin?
Lowest listed price on BodyHackGuide: Cartalax from $49.99, Humanin from $85.60. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.
Can you stack Cartalax and Humanin?
Stacking depends on mechanism overlap, safety profile, and goals. Cartalax and Humanin should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy Cartalax or Humanin
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. We earn an affiliate commission on some outbound clicks, and every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.